IGF1 and COVID-19: Interestingly, following SARS-CoV-2 infection, several studies have found a possible association between low IGF-1 levels (and possibly GH) and poor outcomes in patients with COVID-19 101, 102, while a lower rate of positive SARS-CoV-2 infection was observed in children receiving GH replacement therapy 100.